Browsing: Gynecological

Top Line: Are neoadjuvant chemotherapy and surgery better than chemoradiation for IB2, IIA2, and IIB cervical cancer? The Study: Concurrent…

This pooled analysis of prospective cohorts of >332 K Asian women confirms surrogates of lower lifetime estrogen exposure including older…

Does more aggressive local therapy improve survival for patients with metastatic cervical cancer? In this retrospective study, 164 patients with…

Top Line: Should molecular classification be used to determine the benefit of adjuvant radiation for stage I endometrial cancer?The Study:…

This review article!https://www.practicalradonc.org/article/S1879-8500(23)00176-5/fulltext highlights that over a quarter of endometrial cancers are mismatch repair-deficient (dMMR), microsatellite instability-high (MSI-H). While this…

A Chinese phase 3 trial demonstrates the addition of the maintenance PARP-inhibitor niraparib following debulking surgery and first-line platinum chemo…

Does the length of vagina treated with adjuvant HDR brachytherapy affect toxicity and recurrence outcomes for patients with high risk…

Over one-third of high-grade serous ovarian cancers have high levels of expression of folate receptor ɑ (FRɑ). You may see…

Top Line: Does adjuvant chemotherapy following definitive chemoradiation for cervical cancer improve survival?The Study: In the OUTBACK trial, 919 patients…

Top Line: Does adjuvant chemotherapy following definitive chemoradiation for cervical cancer improve survival?The Study: In the OUTBACK trial, 919 patients…